AI assistant
Sending…
EXELIXIS, INC. — Director's Dealing 2010
Dec 10, 2010
30561_dirs_2010-12-10_ff6071de-a405-45f0-9a76-fc2bf08703f7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXELIXIS INC (EXEL)
CIK: 0000939767
Period of Report: 2010-12-09
Reporting Person: Schwab Gisela (EVP & Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-12-09 | Common Stock | S | 4112 | $6.50 | Disposed | 7322 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3274.5476 | Indirect |
Footnotes
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 26, 2010.
F2: Shares acquired pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan.
F3: Includes 7,322 shares of common stock acquired pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan.
F4: Represents 3,274 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated December 9, 2010.
More from EXELIXIS, INC.
Regulatory Filings
2026
May 29
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 21